SEC Form D · filed January 21, 2022
Solve Therapeutics, Inc
Offering
$126.5M
Sold
$63.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BELMONT, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (4)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗